Scinai Immunotherapeutics (SCNI) Assets Average (2018 - 2025)

Scinai Immunotherapeutics has disclosed Assets Average across 7 years of filings, most recently posting $9.8 billion for Q4 2025.

• Assets Average for Q4 2025 came in at $9.8 billion, up 76090.59% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.8 billion (up 76090.59% YoY), and the FY2025 annual result was $9.8 billion, up 63255.27% from the prior year.
• Assets Average came in at $9.8 billion for Q4 2025 at Scinai Immunotherapeutics, up from $12.6 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $9.8 billion in Q4 2025 to a low of $12.6 million in Q2 2025.
• The 5-year median for Assets Average is $19.2 million (2023), against an average of $771.2 million.
• Across the five-year window, Assets Average sank 31.45% in 2024 and jumped 76090.59% in 2025, its largest moves.
• Scinai Immunotherapeutics' Assets Average stood at $28.6 million in 2021, then slipped by 15.71% to $24.1 million in 2022, then fell by 25.13% to $18.0 million in 2023, then slipped by 28.69% to $12.9 million in 2024, then surged by 76090.59% to $9.8 billion in 2025.
• The last three Assets Average figures came in at $9.8 billion (Q4 2025), $12.6 million (Q2 2025), and $12.9 million (Q4 2024), per Business Quant data.